bpc 157 fda status 2025 Peptide Reclassification 2026: What It Means for Providers What to Watch: Status Update

The distinction between CPT 20605 (intermediate joints) and CPT 20610 (major joints) matters most for elbow, wrist, and ankle claims: the primary large articulations at these locations (tibiotalar, humeroulnar, and radiocarpal) qualify for CPT 20610, while smaller associated articulations at the same anatomical region qualify for CPT 20605

Confounding factors: Natural disease fluctuation, seasonal variations, medication changes, other health changes (new diabetes diagnosis, blood pressure changes)

Pleguezuelos O, James E, Fernandez A, Lopes V, Rosas LA, Cervantes-Medina A, et al

NNMT upregulation was documented to elevate homocysteine levels, activating pro-inflammatory and pro-oxidative cascades including TLR4-NF-B and STAT3-IL-1 signalling